The RNF213 Gene Moyamoya Disease Type 2 Susceptibility genetic test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify mutations in the RNF213 gene, which have been closely linked to the susceptibility of developing Moyamoya Disease Type 2, a rare, progressive cerebrovascular disorder. The condition is characterized by the narrowing of arteries in the brain, leading to reduced blood flow, potential blood clots, strokes, and transient ischemic attacks (TIAs). Identifying the genetic predisposition to this disease is crucial for early intervention and management strategies.
The test involves a comprehensive analysis of the RNF213 gene to pinpoint specific mutations associated with the disease. This genetic testing is pivotal for individuals with a family history of Moyamoya Disease or those who exhibit symptoms suggestive of this condition, offering them a clear understanding of their risk factors.
Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, the test ensures accuracy and reliability. The cost of the RNF213 Gene Moyamoya Disease Type 2 Susceptibility genetic test is 4400 AED. The price reflects the sophisticated technology and expertise required to perform this detailed genetic analysis. By opting for this test, individuals gain invaluable insights into their genetic makeup, empowering them with the information needed to make informed health decisions in collaboration with healthcare professionals.
The GUCY1A3 Gene Moyamoya Type 6 with Achalasia Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GUCY1A3 gene associated with the development of Moyamoya disease type 6, coupled with achalasia. Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing of arteries in the brain, leading to reduced blood flow, while achalasia is a disorder affecting the esophagus, making it difficult for food and liquid to pass into the stomach. The co-occurrence of these conditions suggests a specific genetic component, which this test aims to pinpoint for diagnostic, treatment planning, and genetic counseling purposes. The test is priced at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed to achieve accurate results. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test represents a crucial step forward in the personalized care and management of patients affected by these rare conditions.
The LPIN1 gene myoglobinuria acute recurrent genetic test is a specialized diagnostic tool designed to identify mutations in the LPIN1 gene, which are associated with acute recurrent myoglobinuria. Myoglobinuria is a condition characterized by the presence of myoglobin in the urine, typically resulting from muscle damage. When the LPIN1 gene is mutated, it can lead to episodes of rhabdomyolysis, where muscle fibers break down rapidly, releasing myoglobin into the bloodstream, and subsequently, the urine. This condition can cause acute kidney injury and other serious health issues.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The test involves analyzing the patient's DNA to detect any genetic alterations in the LPIN1 gene that might predispose them to episodes of acute recurrent myoglobinuria. This test is crucial for individuals who have experienced unexplained episodes of muscle pain, weakness, or dark-colored urine, as it can help in the diagnosis and management of the condition. Early identification of the genetic mutation can lead to better management strategies, including lifestyle adjustments and medical interventions to prevent or minimize the impact of rhabdomyolysis episodes.
The ISCU Gene Myopathy with Lactic Acidosis Hereditary Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ISCU gene, which are implicated in the development of a rare genetic disorder. This condition is characterized by muscle weakness (myopathy) and elevated levels of lactic acid in the body (lactic acidosis), which can lead to various health issues. The test is crucial for individuals showing symptoms of the disorder or those with a family history, as early detection can significantly aid in managing the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze and interpret genetic data. This test represents a vital resource for affected families, providing them with essential information for making informed health and lifestyle decisions.
The SLC6A2 Gene Orthostatic Intolerance Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SLC6A2 gene that are associated with orthostatic intolerance (OI). Orthostatic intolerance is a condition characterized by the body's inability to properly regulate blood pressure and blood flow when a person moves from a lying down to a standing up position, leading to symptoms like dizziness, fainting, and rapid heartbeat.
This genetic test plays a crucial role in understanding the genetic predisposition of an individual towards developing OI, thereby facilitating early intervention, personalized treatment plans, and better management of symptoms. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic variations in the SLC6A2 gene that have been linked to the condition.
The cost of the SLC6A2 Gene Orthostatic Intolerance Genetic Test at DNA Labs UAE is 4400 AED. This investment can be invaluable for individuals experiencing symptoms of OI, or for those with a family history of the condition, as it provides critical insights into their health and guides both patients and healthcare providers towards more effective care strategies.
The RASA1 Gene Parkes Weber Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the RASA1 gene, which are associated with Parkes Weber Syndrome. Parkes Weber Syndrome is a rare congenital condition characterized by a constellation of symptoms including arteriovenous malformations, capillary malformation-arteriovenous malformations, and limb overgrowth. The test is crucial for individuals showing symptoms of the syndrome or those with a family history of the condition, as it can provide definitive genetic evidence of the disorder. Conducted through a blood sample, the analysis focuses on detecting genetic alterations in the RASA1 gene that are known to contribute to the development of this syndrome. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it offers into the patient's condition, paving the way for targeted management and treatment strategies.
The SERPINE1 gene plays a crucial role in the regulation of fibrinolysis, a process involved in blood clotting and breakdown. Mutations in this gene can lead to either an increase or decrease in the activity of its product, plasminogen activator inhibitor-1 (PAI-1), which can have significant implications for cardiovascular health and other conditions. The Plasminogen Activator Inhibitor Type 1 (PAI-1) Genetic Test specifically looks for genetic variations in the SERPINE1 gene to assess an individual's risk related to blood clot formation and cardiovascular diseases.
At DNA Labs UAE, this test is offered to individuals who are seeking to understand their genetic predisposition to conditions influenced by PAI-1 levels. It can be particularly beneficial for those with a family history of cardiovascular diseases or thrombosis. The test involves a simple procedure, usually requiring a blood sample or a cheek swab, which is then analyzed for specific genetic markers within the SERPINE1 gene.
The cost of the Plasminogen Activator Inhibitor Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the comprehensive analysis of the SERPINE1 gene to identify any mutations that may affect PAI-1 activity. The results from this test can provide valuable information for personalized medical care, helping healthcare providers to tailor treatments and preventive measures based on an individual's genetic makeup.
The ADA2 Gene Polyarteritis Nodosa Childhood-Onset Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ADA2 gene, which are linked to the development of Polyarteritis Nodosa (PAN) in children. PAN is a rare vascular disorder that causes inflammation of small and medium-sized arteries throughout the body, leading to a wide range of symptoms, including fever, fatigue, weight loss, muscle and joint pain, and severe organ damage. Early and accurate diagnosis through genetic testing can be crucial in managing and treating this condition effectively.
The test specifically looks for genetic variations in the ADA2 gene, which plays a significant role in the immune system's functioning. Mutations in this gene can lead to a deficiency in ADA2 enzyme activity, contributing to the development of the disease. By identifying these genetic mutations, healthcare providers can confirm a diagnosis of PAN, differentiate it from other similar conditions, and tailor treatment plans to the individual's genetic makeup, potentially improving outcomes.
This genetic test is conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic services and genetic testing capabilities. The cost of the ADA2 Gene Polyarteritis Nodosa Childhood-Onset Genetic Test is 4400 AED, reflecting the specialized nature of the test and the sophisticated technology used in its execution. Families considering this test for their children can expect a thorough diagnostic process, supported by the expertise of the medical and scientific team at DNA Labs UAE, to help manage this challenging condition more effectively.
The "PROC Gene Protein C Deficiency AD Genetic Test" is a specialized diagnostic examination conducted to detect mutations in the PROC gene, which is responsible for the production of Protein C. Protein C is a crucial anticoagulant that plays a significant role in preventing excessive blood clotting. Deficiency in Protein C can lead to an increased risk of developing dangerous blood clots, a condition known as thrombophilia. This genetic predisposition is often inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene can cause the disorder.
The test is particularly recommended for individuals with a family history of Protein C deficiency or those who have experienced unexplained blood clotting events. By analyzing the DNA, the test can identify specific mutations in the PROC gene, thereby helping in the diagnosis of Protein C deficiency. This information is crucial for managing the condition, which may involve preventive measures or treatment to reduce the risk of blood clots.
This genetic test is available at DNA Labs UAE, a leading facility that specializes in a wide range of genetic testing services. The cost of the PROC Gene Protein C Deficiency AD Genetic Test is 4400 AED. The test requires a simple blood sample from the patient, and the results are typically available after a few weeks. The outcome of this test can provide valuable insights into the patient's genetic predisposition to blood clotting disorders, aiding in the development of a personalized management plan to mitigate health risks associated with Protein C deficiency.
The PROS1 gene is responsible for the production of Protein S, a crucial anticoagulant in the human body that helps prevent excessive blood clotting. A deficiency in Protein S can lead to an increased risk of developing dangerous blood clots, a condition that can manifest in various serious health issues, including deep vein thrombosis and pulmonary embolism. This condition is often inherited in an autosomal dominant manner, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder.
To diagnose Protein S deficiency linked to the PROS1 gene, a genetic test is available. This test is designed to identify mutations in the PROS1 gene that could lead to Protein S deficiency. Conducted at DNA Labs UAE, the genetic test is a critical tool for individuals with a family history of blood clotting disorders or those who have experienced unexplained thrombotic events. Early detection through this test can be instrumental in managing the condition, implementing preventive measures, and reducing the risk of complications associated with excessive blood clotting.
The cost of the PROS1 gene Protein S deficiency autosomal dominant genetic test at DNA Labs UAE is 4400 AED. This investment in health allows individuals to gain valuable insights into their genetic makeup, empowering them with the knowledge to take proactive steps in managing their health and preventing potential blood clotting disorders.
